Pharmaceutical companies require educators who can tailor their training to meet he specific needs of healthcare providers
Lillys next-generation weight-loss pill orforglipron could be approved as soon as late March
Mol Psychiatry (2012) 17(3):290314
Unique Aspect: Its high concentration of peptides and modern encapsulation technology helps deliver active ingredients deeper into the skin layers
Lyophilized peptides are stable, but once they're in liquid form, they must be handled gently
DJD has received consulting fees from Amgen, Alnylam, AstraZeneca Inc., Crinetics, Eli Lilly, General Medicines Inc., Kallyope, Metsera, Pfizer Inc., Protagonist Therapeutics Inc., and Sanofi and speaking fees from Novo Nordisk Inc